9 METERS BIOPHARMA INC (NMTR)
US6544052086 - Common Stock
| MRQ (2023-3-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | N/A | |||
| Cash Equivalents | 6.94M | 12.65M | 46.99M | 37.85M | 4.59M | |||
| Receivables | N/A | N/A | N/A | N/A | N/A | |||
| Inventories | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 2.26M | 20.37M | 2.99M | 1.08M | 640.00K | |||
| Total Current Assets | 9.20M | 33.02M | 49.99M | 38.93M | 5.22M | |||
| Non-Current Assets | ||||||||
| PPE Net | 106.75K | 122.72K | 182.71K | 230.00K | 70.00K | |||
| Intangibles | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 8.98K | 7.28K | 5.58K | 10.00K | 10.00K | |||
| Total Non-Current Assets | 115.74K | 129.99K | 188.30K | 230.00K | 80.00K | |||
| TOTAL ASSETS | 9.31M | 33.15M | 50.17M | 39.16M | 5.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 10.00K | 3.18M | |||
| Current Portion Of LT Debt. | 5.07M | 19.62M | N/A | N/A | N/A | |||
| Accrued Expenses | 5.82M | 4.44M | 6.02M | 5.34M | 4.79M | |||
| Accounts Payable | 4.23M | 5.05M | 2.43M | 1.49M | 3.89M | |||
| Other Current Liabilities | 454.00K | 1.58M | 0.00 | 10.00K | 3.05M | |||
| Total Current Liabilities | 15.58M | 30.70M | 8.46M | 6.85M | 14.91M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 34.77K | 51.40K | 113.14K | 170.00K | N/A | |||
| Total Non-Current Liabilities | 34.77K | 51.39K | 113.14K | 170.00K | 0.00 | |||
| TOTAL LIABILITIES | 15.61M | 30.75M | 8.57M | 7.02M | 14.91M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -226.48M | -212.61M | -168.84M | -132.06M | -70.56M | |||
| Additional Paid In Capital | 220.17M | 215.01M | 210.42M | 164.18M | 60.95M | |||
| Common Shares | 1.43K | 1.30K | 25.82K | 20.00K | 0.00 | |||
| Shares Outstanding | 14.34M | 13.04M | 12.91M | 204.63M | 39.48M | |||
| Tangible Book Value per Share | -0.44 | 0.18 | 3.22 | 0.16 | -0.24 | |||
| Total Shareholders' Equity | -6.30M | 2.40M | 41.60M | 32.14M | -9.61M | |||
| TOTAL LIABILITIES AND EQUITY | 9.31M | 33.15M | 50.17M | 39.16M | 5.30M | |||
| Statistics | ||||||||
| Current Ratio | 0.59 | 1.08 | 5.91 | 5.68 | 0.35 | |||
| Return On Assets (ROA) | -496.97% | -132.03% | -73.30% | -157.05% | -510.38% | |||
| Return On Equity (ROE) | N/A | -1823.19% | -88.40% | -191.35% | N/A | |||
All data in USD